Mission
THE FOUNDATION RAISES FUNDS FOR RESEARCH OF THE DISEASE KNOWN AS HYPERTROPHIC CARDIOMYOPATHY.
Small Public Charity
THE HYPERTROPHIC CARDIOMYOPATHY RESEARCH FOUNDATION INC
THE HYPERTROPHIC CARDIOMYOPATHY RESEARCH FOUNDATION INC is a Small Public Charity headquartered in RYE, NY. Financial data from the 2025 filing: $52K revenue, $28K expenses, $26K total assets. 10 publicly reported grants to this organization, totaling roughly $142K, appear in IRS filings.
EIN: 134162139
RYE, NY
Latest filing: 2025
Total Revenue$52K
Total Expenses$28K
Total Assets$26K
Grant Records10
Funding Total$142K
Filing Years2020–2025
Sample Grants Received
H43 HEART AND CIRCULATORY
$25,000
IN FURTHERANCE OF GRANTEE'S TAX-EXEMPT PURPOSE
$20,050
PUBLIC, SOCIETAL BENEFIT
$11,000
IN FURTHERANCE OF GRANTEE'S TAX-EXEMPT PURPOSE
$10,050
DAF - Health Care & Research
$10,000
Showing up to 5 of 10 total records — full history available with membership.
Officers & Directors
DIRECTOR
Barbara Novick
DIRECTOR
Dr Eugene Musser
DIRECTOR
Dr Jonathan Rosenfeld
DIRECTOR
Howard Mirchin
PRESIDENT
John D Lium
TREASURER
John M Lium
Officer compensation and complete director data available with membership.
Top Grant Purposes
Financial Trends
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2025 | $52K | $28K | $26K |
| 2024 | $23K | $24K | $2K |
| 2023 | $82K | $81K | $3K |
| 2021 | $39K | $38K | $4K |
| 2020 | $33K | $36K | $3K |
Between 2020 and 2025, reported annual revenue grew from $33K to $52K (+57%), with total assets most recently reported at $26K.
Interactive year-over-year charts and full filing details available with membership.